CATALENT PHARMA SOLUTIONS INC SR GLBL 144A 27's ticker is and the CUSIP is 14879EAE8. A total of 1 filers reported holding CATALENT PHARMA SOLUTIONS INC SR GLBL 144A 27 in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $107,647 | +0.1% | 117,000 | 0.0% | 0.00% | – |
| Q2 2023 | $107,576 | -46.7% | 117,000 | -45.6% | 0.00% | -100.0% |
| Q2 2022 | $202,000 | -95.7% | 215,000 | -95.2% | 0.00% | -97.0% |
| Q2 2021 | $4,704,000 | +71.8% | 4,495,000 | +72.2% | 0.07% | +39.6% |
| Q1 2021 | $2,738,000 | +223.6% | 2,610,000 | +226.2% | 0.05% | +200.0% |
| Q4 2020 | $846,000 | +1.6% | 800,000 | 0.0% | 0.02% | -11.1% |
| Q3 2020 | $833,000 | +0.1% | 800,000 | 0.0% | 0.02% | +5.9% |
| Q2 2020 | $832,000 | – | 800,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pacer Advisors, Inc. | 117,000 | $107,647 | 0.00% |